Transcutan

Next generation access solutions with fewer complications

Transcutan - innovation in intracorporeal access

Since 2017, Hammarplast Medical is the majority shareholder in Transcutan AB, a company at the forefront of intracorporeal access solutions. Transcutan was founded in 2001 at Uppsala University Hospital and Sahlgrenska University Hospital, where the vision was to create the next generation of medical innovations.

By combining Transcutan's groundbreaking innovations with Hammarplast Medical's manufacturing expertise and quality focus, we strive to create products that improve patients' quality of life and meet the future needs of healthcare.

TauroLock™

Since 2016, Transcutan has also been a distributor of TauroPharm's antimicrobial catheter lock solutions, TauroLock™ and NutriLock™, which strengthens their offering in patient safety and infection prevention.

TauroLock™ is a world-leading range of products used to keep long-term catheters clean, infection-free and flow-proof.